Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Can Puma’s Radical Overhaul Reverse Its Downward Spiral?

Andreas Sommer by Andreas Sommer
October 24, 2025
in Analysis, Consumer & Luxury, MDAX & SDAX, Turnaround
0
Puma Stock
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

The German sportswear giant Puma is fighting for its survival. With shares plummeting more than 50% since the start of the year and a severe profit warning issued in July, the company is initiating a drastic corporate restructuring. A new retail chief is at the center of this make-or-break strategy, but market observers question whether a personnel change alone can halt the decline.

Financial Reality Bites

Behind the corporate reshuffling lies a stark financial picture. The company’s outlook for 2025 has shifted dramatically, with management now anticipating:

  • A low double-digit percentage decline in revenue
  • An EBIT loss, a stark reversal from the previously forecasted profit of €445-525 million
  • A reduction in planned investments from €300 million to €250 million

This weakness is widespread, affecting all of Puma’s key regional markets. North America saw sales contract by 9.1%, while Europe and China each declined by 3.9%. The stock currently trades near €22, a level that places it more than 50% below its 52-week high and a mere 30% above its lowest point. A Relative Strength Index (RSI) reading of 26.2 further indicates the equity is technically deeply oversold.

A Veteran Takes the Helm

In a decisive move, Puma has appointed Ronald Reijmers, a 55-year-old industry veteran, to lead its global retail operations. Reijmers brings nearly three decades of experience from tenures at rivals Nike and Adidas, and most recently, at Gymshark. His start date of November 1 coincides with a major internal shift: the division of Puma’s direct-to-consumer organization into two distinct units.

Should investors sell immediately? Or is it worth buying Puma?

While Reijmers takes command of the physical retail business, the company is still searching for a leader to head the separate e-commerce division. Erik Janshen, the former executive in charge, is departing. The message from headquarters is unequivocal—the status quo is no longer acceptable.

The Countdown to Clarity

The critical question for investors is whether these organizational reforms and leadership changes will be enough to stabilize the company. A significant test arrives on October 30, when Puma is scheduled to release its third-quarter earnings.

Market experts are focusing on two key areas for evidence of progress. First, they will scrutinize whether Puma is successfully managing its inventory levels. Second, analysts will be looking for any early signs that cost-cutting initiatives are beginning to yield positive results.

Time is of the essence for the sportswear firm. As the new retail chief prepares to assume his role, the company is contending with a multi-front battle against US tariffs, persistently weak consumer demand, and a profound loss of investor confidence. The upcoming quarterly report will serve as a crucial indicator, revealing whether the rescue measures are taking hold or if the downward trajectory is set to continue.

Ad

Puma Stock: Buy or Sell?! New Puma Analysis from February 7 delivers the answer:

The latest Puma figures speak for themselves: Urgent action needed for Puma investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Puma: Buy or sell? Read more here...

Tags: Puma
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Potbelly Stock
Analysis

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026
Next Post
CureVac Stock

CureVac Acquisition Enters Final Phase as BioNTech Makes Formal Bid

Novo Nordisk Stock

Leadership Shakeup at Novo Nordisk Sparks Investor Uncertainty

BASF Stock

A Tale of Two Titans: Comparing Investment Strategies in Germany's Chemical Sector

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com